All Type of News


High expectation in health insurance benefit negotiation with Jae-In Moon administration’s ‘reasonable benefits, reasonable burden’

The first 2018 health insurance benefit negotiation was completed for each association. Negotiation teams, which took a brief look at the entire negotiation process, expressed that increases in the health insurance b...

Dong Wha Pharm acquires license to sell all the GSK’s OTC products worth of KRW 55 billion

Dong Wha Pharm has risen as the strongest in selling OTC drugs. According to the industry concerned, Dong Wha Pharm was known to sign an agreement of selling all the GSK’s OTC products(total 10 products) with GSK on ...

Female ratio to total executives was only 7% in listed pharmas

Less than 1 of 10 executives working for Korean listed pharmaceutical companies were women. According to the Yakup Shinmoon’s(www.yakup.com) analysis result of the executive status(including registered and unregister...

“Health insurance benefits for pharmacy must reflect the reality of the industry”

The Korean Pharmaceutical Association’s National Health Insurance Benefit Negotiation Team(Team Leader In-Choon Park, Mo-Sae Park, Yang-Yeon Cho, Yong-Hwa Lee) informed difficulties in managing pharmacies to the Natio...

Hanmi Pharm acquires world’s first approval of combination drug for treatment of both asthma and allergic rhinitis

Hanmi Pharm(CEO Jong-Soo Woo, Sae-Chang Kown) announced on the 17th that it acquired commercialization approval of ‘Monterizine,’ a combination drug for patients with both asthma and allergic rhinitis(allergic rhiniti...

No updates for settling balance for differences on targeted therapy for cancer ‘Tarceva’

The pharmaceutical distribution industry raised complaints since they have not been able to settle balance for differences generated by the drug price cut of ‘Tarceva,’ a Roche Korea’s targeted therapy for cancer. Th...

Intensified polarization in R&D investment among listed pharms

Although it is estimated there were more than 6 listed pharmaceutical companies investing more than KRW 100 billion into R&D in a year, there were also a number of pharmaceutical products spending less than 1% of thei...

5-Year-Cyle Pharmaceutical Product Renewal System to be enforced from this June

A policy for pharmaceutical products to get approval and renewal every 5 years will be enforced from the coming June. The Ministry of Food and Drug Safety(MFDS) announced enforcement of the Pharmaceutical Product Ren...

5-Year-Cyle Pharmaceutical Product Renewal System to be enforced from this June

A policy for pharmaceutical products to get approval and renewal every 5 years will be enforced from the coming June. The Ministry of Food and Drug Safety(MFDS) announced enforcement of the Pharmaceutical Product Ren...

Asan Medical Center opens Korea’s first imaging core lab, ‘AIM’

On the 16th, Asan Medical Center held a symposium to celebrate the ‘Selection of the Clinical Trial Development Project for High-Tech Conversance and Opening of AIM(Asan Image Metrics)’ at Asan Medical Center Asan Ins...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.